Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson
From Blood Cancer Talks by Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
August 20, 2025 · 43 min · Episode 65
About this episode
Dr. Adrian Minson discusses the latest lymphoma developments from EHA and ICML 2025, focusing on bispecific antibodies and key clinical trials.
In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA and ICML meetings in June 2025. The episode focuses primarily on the emerging role of bispecific antibodies in various combinations and treatment settings for diffuse large B-cell lymphoma (DLBCL). Key Clinical Trials Discussed 1. POLARGO Trial - Polatuzumab + R-GemOx vs R-GemOx in R/R DLBCL 2. SUNMO Trial - Mosunetuzumab + Polatuzumab vs R-GemOx in R/R DLBCL 3. STARGLO Trial - Glofitamab + GemOx vs R-GemOx in R/R DLBCL (2-Year Update) 4. EPCORE NHL-5 & NHL-7 - Epcoritamab Combinations in Frontline DLBCL 5. EPCOR-RICE - Epcoritamab + R-ICE in Transplant-Eligible R/R DLBCL 6. LOTIS-7 Trial - Loncastuximab + Glofitamab in R/R DLBCL 7. Additional Studies Mentioned: R-Pola-Glo Frail Study DLBCL Classification
People in this episode
Hosts: Rajshekhar Chakraborty, Ashwin Kishtagari, Edward Cliff
Guest: Dr. Adrian Minson
Topics covered
- lymphoma updates
- clinical trials
- bispecific antibodies
- diffuse large B-cell lymphoma
- cancer treatment
- EHA and ICML meetings
Keywords
- lymphoma
- clinical trials
- bispecific antibodies
- DLBCL
- EHA
- ICML
- cancer treatment
Mentioned in this episode
Organizations: Peter MacCallum Cancer Centre
Products: bispecific antibodies, Polatuzumab, R-GemOx, Mosunetuzumab, Glofitamab, Epcoritamab, Loncastuximab
Books & works: diffuse large B-cell lymphoma (DLBCL)
More episodes of Blood Cancer Talks
- Episode 71. Management of Newly Diagnosed Multiple Myeloma with Dr. Vincent Rajkumar · May 19, 2026 · 52 min
- Episode 70. ASH 2025 Myeloid Neoplasm Roundup with Dr. Curtis Lachowiez · February 27, 2026 · 57 min
- Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casulo · January 22, 2026 · 44 min
- Episode 68. ASH 2025 Myeloma Special: MajesTEC-3 and the Bispecific Revolution with Dr. Luciano Costa · January 2, 2026 · 46 min
- Episode 67. Management of CMV in Hematologic Malignancies · November 23, 2025 · 40 min
- Episode 66. International Myeloma Society 2025 Annual Meeting Updates with Dr. Alfred Garfall: The Bispecific Bonanza · October 15, 2025 · 52 min
Explore listener stats, chart rankings, contacts and more on the Blood Cancer Talks podcast page.